Last edition
News about
AstraZeneca to Build Cell Therapy Hub and Innovation Centre in Shanghai
AstraZeneca has announced plans to set up a new cell therapy manufacturing and supply base along with an innovation centre in Shanghai, strengthening its presence in one of its key global markets.
Novartis Signs Deal with Synnovation Therapeutics to Explore Next-Gen Breast Cancer Treatment
Novartis has signed a deal with Synnovation Therapeutics to advance SNV4818, a next-generation PI3Kα inhibitor in phase-I/II trials, targeting HR+/HER2- breast cancer patients with PIK3CA mutations, addressing a significant unmet need.
FDA Approves Rhythm Pharma's IMCIVREE for Acquired Hypothalamic Obesity
Rhythm Pharmaceuticals has received US Food and Drug Administration (FDA) approval for IMCIVREE, the first and only treatment for acquired Hypothalamic Obesity (HO), supported by phase-III data showing a 18.4 percent placebo-adjusted BMI reduction in patients aged four years and older.
Lilly's Retatrutide Shows Strong A1C, Weight Reduction in Phase-III Diabetes Trial
Eli Lilly’s Retatrutide reduced A1C by up to two percent and delivered average weight loss of 36.6 lbs in its phase-III TRANSCEND-T2D-1 trial, with continued weight reduction observed through 40 weeks in type-II diabetes mellitus patients.
Fauna Bio Announces Target Designation Milestone in Obesity Discovery Collaboration
Fauna Bio has achieved a target designation milestone in its obesity discovery collaboration, advancing a novel target identified through its Convergence AI platform.
LGM Pharma Expands US Manufacturing, Invests USD 15 Million in Texas and Colorado
LGM Pharma has expanded its US manufacturing with a total USD 15 million investment across Texas and Colorado, boosting CDMO capacity for suppository, semi-solid and oral solid dose production while strengthening domestic supply chains for finished dosage manufacturing.
Lupin Manufacturing Solutions Scales Up Dabhasa Manufacturing Facility
Lupin Manufacturing Solutions has expanded its Dabhasa facility with a new block and dedicated peptide manufacturing units, strengthening its CRDMO capabilities and boosting capacity for advanced pharma development and production.
Sobi Presents Positive Phase IIa Data for Gamifant in Interferon-Driven Sepsis
Sobi reports encouraging Phase IIa EMBRACE study results showing potential of Gamifant in interferon-gamma-driven sepsis, supporting precision medicine approaches in treating high-risk patients.
Mabtech, Sai Life Sciences Partner to Expand Advanced Immunology Services in the U.S.
Mabtech and Sai Life Sciences collaborate to deploy EYRA multiplex platform in Boston, enhancing access to advanced immune profiling for biopharma and biotech research.
Illumina, Labcorp Expand Partnership to Boost Access to Precision Oncology Testing
Illumina and Labcorp deepen collaboration to expand next-generation sequencing-based cancer testing, improve access to biomarker diagnostics, and accelerate development of precision oncology solutions.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy